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 Quantitative features of dose responses were analyzed for 2,189 candidate anticancer
agents in 13 strains of yeast (Saccharomyces cerevisiae). The agents represent a diverse class
of chemical compounds including mustards, other alkylating agents, and antimetabolites,
inter alia. Previous analyses have shown that the responses below the toxic threshold were
stimulatory and poorly predicted by a threshold dose-response model, while better
explained by a hormetic dose-response model. We determined the quantitative features of
the hormetic concentration-responses (n = 4,548) using previously published entry and
evaluative criteria. The quantitative features that are described are: (1) the width of the
concentration range showing stimulation above 10% of the control (mean of 5-fold),
(2) the maximum stimulation of the concentration-responses (mean of 27% above the
control), and (3) the width from the maximum stimulation to the toxicological threshold
(mean of 3.7-fold). These results show that 52.5% of the 2,189 chemicals evaluated display
hormetic concentration-responses in at least one of the 13 yeast strains. Many chemicals
showed hormesis in multiple strains, and 24 agents showed hormesis in all 13 strains. The
data are compared to previously reported quantitative features of hormesis based on pub-
lished literature.
Keywords: hormesis, threshold, yeast, biphasic, low-dose, anti-tumor
INTRODUCTION
This study presents an analysis of the concentration-response relation-
ships of 2,189 candidate anticancer compounds evaluated by the National
Cancer Institute (NCI) in its Yeast Anticancer Drug Screen (Holbeck
2004; Holbeck and Simon 2007). These compounds were tested on a
panel of 13 yeast strains, each having one or two mutations affecting dam-
age-response functions (DNA damage repair or cell cycle control) homol-
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ogous to those mutated in human cancers. Previous analyses of these NCI
data have shown that responses below the toxic threshold were poorly pre-
dicted by the threshold model, yet highly consistent with a hormetic,
inverted U-shaped concentration-response model (Calabrese et al. 2006a,
2008). The initial studies evaluated the individual responses of concentra-
tions and their replication below estimated Benchmark Doses (BMDs) but
they did not explore the individual concentration-response relationships
or the magnitude of stimulation with respect to hormesis. This presenta-
tion extends the initial reports by addressing each of these limitations.
Hormesis is a dose-response relationship that represents either over-
compensation to a disruption in homeostasis or a direct stimulatory
response (Calabrese and Baldwin 2002). The quantitative features of
both of these types of hormetic responses are similar, with the magnitude
of the maximum stimulatory response typically being 30-60% greater
than controls, the width of the stimulatory or hormetic zone averaging
approximately 10-fold, and the interval from the zero equivalent point to
the maximum stimulation averaging 4- 5-fold (see Figure 1; Calabrese
and Baldwin 1997; Calabrese and Blain 2005).
The work presented here extends the findings of Calabrese et al.
(2006a, 2008) by evaluating the quantitative features of the hormetic con-
centration-responses in the NCI Yeast Anticancer Drug Screen database.
The individual hormetic concentration-responses in this paper were
quantified by measuring the width of the hormetic zone, the interval
from the maximum stimulatory concentration to the zero equivalent
point, and the amplitude of the maximum stimulation. These data were
then compared to quantitative features of previously described hormetic
dose-responses in other biological model systems following exposure to
chemicals or radiation (Calabrese and Blain 2005).
This paper represents the first work that focuses entirely on quanti-
tative features of hormetic responses in a single large-scale study (e.g.,
the NCI Yeast Anticancer Drug Screen). It thus complements and
extends previous analyses that quantitatively described dose-response
relationships in published literature (Calabrese and Blain 2005). This
analysis has the advantage of exploring 28,457 concentration-responses
that were derived from identical experiments conducted in the same
laboratory.
METHODS
NCI Laboratory Methods
The NCI data that are used in this evaluation are from the “Stage 2”
Yeast Anticancer Drug Screen (YACDS) and are available to the public on
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the Internet (http://dtp.nci.nih.gov/yacds/download.html). The data
set has been described by Holbeck (2004) and by Holbeck and Simon
(2007). Our use of the database for the study of hormesis is consistent
with the methods of Calabrese et al. (2006a, 2008). This analysis includes
2,189 agents that were tested at five concentrations (1.2, 3.7, 11, 33, and
100 μM) in 13 genetically different yeast strains. Most of the strains har-
bor one or two mutations in genes involved in DNA damage repair (mgt1,
mlh1, rad14, rad18, rad50, rad52 or sgs1) or cell cycle control (bub3,
CLN2oe or mec2). Descriptions of the genotypes are on the NCI website
[http://dtp.nci.nih.gov/yacds/exp_design.html]. This group of geneti-
cally altered Saccharomyces cerevisiae strains is collectively referred to as the
yeast panel and it represents 11 strains with genetic alterations and two
“wild-type” strains. The latter, designated wt and SPY50780, are not classi-
cally defined wild types but are wild type with respect to the DNA damage
and cell cycle control genes in the other 11 strains.
The available data are derived from the fraction of growth of the yeast
strain exposed to the chemical relative to the growth of the same strain in
a solvent control (i.e., DMSO). Yeast in the exponential phase of growth
were inoculated into synthetic medium containing 2% glucose that
included the chemical agent. The initial cell density was 104 cells per well
containing 200μl of medium.
In the replication procedure each of the 2,189 chemicals was tested
four times at the same five concentrations in each of the 13 strains. Each
96-well plate contained 80 chemicals at the same concentration (either
1.2, 3.7, 11, 33 or 100 μM) with the outer wells serving as controls. Plates
for the five concentrations of each chemical were incubated over the
same 12-hour period. The 16 control wells included four unexposed con-
trols, eight solvent controls, and four controls using cycloheximide. The
assay was considered invalid if there was growth in the presence of cyclo-
heximide as all strains were cycloheximide sensitive.
The available data consist of a ratio of the optical density (OD) at 600
nm of a single response well for the treatment divided by the mean of the
eight OD600 readings of the solvent control wells for each concentration.
This process was repeated on a second day, and the ratios from the two
days were averaged to yield what this paper refers to as a replication
response. Two replication responses were produced for each of the
28,457 experiments, and the data on the NCI website provide the average
of the two replications and the difference between the two values. The
original OD values are not available (see: Calabrese et al. 2006a) the
absolute value of the difference in response between the replications was
provided by the NCI. The replicate values at each concentration were
derived as described by Calabrese et al. (2006a, 2008).
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Selection of Hormetic Concentration-responses
A concentration-response in this study is defined as the response of a
single yeast genotype to a single chemical (referred to as an NSC agent by
the NCI) evaluated over 5 concentrations (1.2, 3.7, 11, 33, and 100 µM).
Hormetic concentration-responses were selected using a priori entry cri-
teria to evaluate the 28,457 individual concentration-response curves in
the NCI “Stage 2” database (NCI 2007). This process ensured that con-
centration-responses displayed evidence of low dose stimulation followed
by higher dose inhibition, and displayed a characteristic β-shaped (invert-
ed U-shaped) concentration-response (Figure 1). The screening proce-
dure used to define an inhibitory response (hmax) and a stimulatory
response (smin) set hmax ≤ 80% of the control response and Smin ≥ 110% of
the control response. These values were consistent with a typical hormet-
ic (β) concentration-response curve (Calabrese and Baldwin 1997).
The chemical concentrations were represented with the subscript i,
where i = 1,…,5 indicates the lowest concentration (1.2 μM) to the high-
est concentration (100μM), the concentration as di , and the correspon-
FIGURE 1. Parameters of the hormetic concentration-response curves (shaded region). (A) The
maximum stimulatory response. (B) The width of the stimulatory response calculated from the low-
est (P1) to the highest (P2) concentration showing a response that is 110% of the control response.
(C) Distance from the concentration of the maximum stimulatory response (Cmax) to the highest
concentration with a response equal to the control, the zero equivalent point (ZEP) [after Calabrese
and Baldwin, 2003]. In order for a concentration-response to be evaluated it had to have a response
in the low-concentration region ≥110% (Smin) and a response at a higher concentration ≤80% (hmax)
of the control.
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ding average response as Yi . Using these definitions, the stimulatory con-
centration was defined as:
ds = min[di | Yi ≥ smin].
This concentration represents the lowest concentration where the
response is greater than or equal to the minimum stimulatory response.
The inhibitory concentration in the concentration-response was
defined as:
dh = min[di | Yi ≤ hmax].
Finally, if the concentration-response had both a dh and a ds and dh>ds,
then the concentration-response for the chemical was classified as having
a hormetic concentration-response.
There was no measure of statistical significance for the individual
mean responses at each of the five concentrations in a given concentra-
tion-response study. Instead, we used criteria established by Calabrese and
Baldwin (1997), as these permitted us to compare hormetic responses in
this tightly defined database with those in the broader toxicological liter-
ature. Thus, if a concentration-response had inhibition below 80% of the
control at the highest concentration, and the remaining 4 concentrations
below the ZEP had mean responses between 100% and 110% of the con-
trol, it would not be included in this analysis. The value of ≥10% above
the controls was chosen as it has been previously used as the “criterion for
evidence of hormesis” when evaluating inverted U-shaped concentration-
responses in dose-range studies (Calabrese and Baldwin 2003).
Quantification of Hormetic Parameters
The features of the hormetic concentration-responses (green pat-
tern/shaded region in Figure 1) that were quantified include the maxi-
mum stimulatory response, the width from the maximum stimulatory
response to the zero equivalent point (ZEP, i.e., the highest dose showing
a response equal to the control response), and the width of the hormet-
ic zone in each of the concentration-response studies.
Maximum Stimulatory Response and the Width from Max Stimulation 
to the ZEP
The maximum stimulatory response (parameter A, Figure 1) is the
response of the greatest magnitude at the 1.2, 3.7, 11, or 33 µM concen-
tration. If the largest response was the same at two concentrations (e.g.,
130% at both the 1.2 and 11 µM concentrations), the lower concentra-
tion was chosen as the Cmax. This was done so as to conservatively estimate
the width of the stimulatory response. The concentration that corre-
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sponds to the maximum stimulatory response is termed the Cmax. The dis-
tance from that concentration to the ZEP is parameter C (i.e., C = ZEP –
Cmax, not; Figure 1). The ZEP was calculated by determining the concen-
tration (on the abscissa) where the response (on the ordinate) is equal to
the control (ordinate value of 100%). The ZEP calculations were per-
formed by interpolating (on the logarithmic scale) the concentration
from the response immediately below and above the ZEP. For example, if
the ZEP falls between the response at the 33 µM and 100 µM concentra-
tion, the ZEP would be:
ZEP = exp[log(33) + ((100 – 33µM Response) × (log(100) –
log(33)))/(100µM Response – 33µM Response)].
Width of the Hormetic Zone
The width of the hormetic zone (parameter B, Figure 1) is defined as
the width of the stimulatory region that is ≥ 110% of the control. It there-
fore extends above and below the concentration of the maximum stimu-
latory response (P2 – P1 = B, Figure 1) but does not reach the ordinate
or the ZEP.
The concentration at which the response is estimated to have
increased 10% above the control value before reaching the concentration
of the maximum stimulatory response (termed P1) was estimated for the
concentration-responses selected for evaluation in this analysis. The aver-
age of two replications expressed as percent of control responses, was
used to determine the 10% increase in response. The P1 was estimated by
the following procedure:
1. If the Cmax = 1.2 µM then let P1 = 1.2 µM. If not, then proceed to step
2.
2. The largest concentration < Cmax with an average response < 110% of
the control was identified. This concentration was defined as P1Xbelow,
and the associated response was termed P1Ybelow.
3. The next highest concentration was defined as P1Xabove, and the asso-
ciated response was defined as P1Yabove.
4. The P1 was then estimated by linear interpolation on the log concen-
tration scale:
P1 = exp[log(P1Xabove) + (110 – P1Yabove)(log(P1Xbelow) –
log(P1Xabove))/(P1Ybelow – P1Yabove)].
The concentration > Cmax where the associated response has
decreased to < 10% above the control value (P2) was similarly estimated
6
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for the concentration-responses from the average of two replications. The
P2 was estimated by the following procedure:
1. The lowest concentration > Cmax with an average response < 110% of
the control was identified. This concentration was termed P2Xbelow,
and the associated response was P2Ybelow.
2. The first concentration immediately < P2Xbelow was defined as
P2Xabove, and the associated response was defined as P2Yabove.
3. The P2 was then estimated by linear interpolation on the log con-
centration scale:
P2 = exp[log(P2Xabove) + (110 – P2Yabove)(log(P2Xbelow) –
log(P2Xabove))/(P2Ybelow – P2Yabove)].
RESULTS
Identification of Hormetic Concentration-Responses
There are a total of 28,457 concentration-responses in the publicly
available “Stage 2” data in the NCI YACDS database (2,189 anticancer
agents × 13 yeast strains). Of those concentration-responses, 78.0% (n =
22,208) have an inhibitory response (h
max
) ≤ 80% of the control. From
those 22,208 responses, 20.5 % (n = 4,548) also have at least one stimula-
tory response (s
min
) ≥ 110% of the control response. These 4,548 con-
centration-responses are the sample described in this study.
Quantification of Hormetic Parameters
The results of these analyses are presented in Table 1. In this evalua-
tion of 4,548 hormetic concentration-responses, the mean maximum stim-
ulatory response (parameter A, Figure 1) is 127.2% of the control with
individual values ranging from 110% to 254%. The mean width of the
hormetic zone (parameter B, Figure 1) was 9.2 μM, with individual con-
centration-responses ranging from 0 to 64.5 µM. The mean distance from
the concentration of the maximum stimulatory response to the ZEP (para-
meter “C”, Figure 1) is 12.3 μM, with individual values ranging from 0.14 to
68.6 μM. The mean ZEP for the 4,548 responses was 16.9 μM (standard
deviation 13.7) with individual ZEP values ranging from 1.3 to 77.4 µM.
DISCUSSION
The results are in general agreement with previous reports of horme-
sis for over 5,600 concentration-response relationships from over 900 dif-
ferent exposures to chemical and radiation stress (Calabrese and Baldwin
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1997; Calabrese and Blain 2005). In those studies, Calabrese and others
reported that the maximum amplitude of the stimulatory response is gen-
erally modest, usually only 30% greater than the control response. They
reported that nearly 80% of the concentration-responses are less than
200% of the control response, which is also in general agreement with the
present evaluation. The mean maximum stimulatory response (parame-
ter A, Figure 1) in the present study was approximately 127% of the con-
trol, being <135% in about 75% of the dose responses
The experimental design with a dose range of ~100-fold (1.2 - 100
μM) was somewhat restrictive in assessing hormetic concentration-
responses given the a priori entry criterion that at least one of the respons-
es must be less than or equal to 80% of the control response (hmax). Thus,
the entry criteria and experimental design limit the width of the maxi-
mum stimulatory zone to approximately 75 μM. Despite the potential lim-
TABLE 1. Parameters of the 4,548 hormetic dose-responses in the YACDS database. The parame-
ters are illustrated in Figure 1.
Concentrations
Parameter Below ZEP N Mean St Dev Q1 Median Q3 Min Max
A 1 438 118.81 9.65 112 115 122 110 173
Maximum 2 1338 125.87 16.07 114 121 133 110 237
stimulation 3 1925 128.53 17.33 115 124 137 110 254
(%) 4 847 130.57 18.25 116 125 141 110 207
All data 4548 127.19 16.85 115 122 135 110 254
B 1 438 0.38 0.34 0.12 0.29 0.55 0 1.85
Width of 2 1338 2.68 1.64 1.34 2.76 3.68 0 7.80
hormetic 3 1925 8.99 5.52 4.37 9.93 12.80 0 24.84
zone 4 847 24.52 14.58 11.95 26.88 35.52 0 64.47
(μM) All data 4548 9.20 10.82 1.57 4.86 12.63 0 64.47
C 1 438 1.18 0.61 0.67 1.13 1.70 0.14 2.35
Maximum- 2 1338 4.00 1.89 2.79 3.66 5.11 0.39 9.45
to-ZEP 3 1925 12.51 5.52 9.17 11.56 15.35 1.18 30.72
interval 4 847 30.56 12.33 24.37 32.33 37.87 3.79 68.60
(μM) All data 4548 12.28 11.69 3.50 8.81 16.03 0.14 68.60
ZEP 1 438 2.38 0.61 1.87 2.33 2.90 1.34 3.55
(μM) 2 1338 6.15 1.85 4.60 5.68 7.49 3.70 10.67
3 1925 16.85 5.03 12.91 15.39 19.35 11.00 32.25
4 847 41.44 7.47 35.94 39.31 44.84 33.00 77.36
All data 4548 16.89 13.73 5.80 12.97 22.39 1.34 77.36
Cmax 1 438 1.20 0.00 1.2 1.2 1.2 1.2 1.2
(μM) 2 1338 2.15 1.21 1.2 1.2 3.7 1.2 3.7
3 1925 4.34 3.86 1.2 3.7 3.7 1.2 11.0
4 847 10.88 11.53 1.2 11.0 11.0 1.2 33.0
All data 4548 4.61 6.46 1.2 1.2 3.7 1.2 33
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itation, the mean width of the hormetic zone was found to be only 9.2 μM
with 75% of the data below 12.6 μM (Table 1). In fact, for the 4,548 con-
centration-responses the width of the stimulatory response extended on
average from 2.3 μM (parameter P1, Figure 1) to 11.5 μM (parameter P2,
Figure 1), thus constituting a 5-fold (11.5/2.3) difference in dose. This
result corresponds well to published hormetic responses for microbial
growth. In an evaluation of 165 dose-response studies involving microbes,
the width of the hormetic zone was between 1 and 10-fold 54% of the
time (Calabrese and Blain 2005). One might expect a homogeneous pop-
ulation to show a narrower range of stimulatory response than that
observed in heterogeneous systems (Calabrese and Blain 2005). This
might explain why 90% of the hormetic concentration-responses in our
study had a stimulatory width less than 25.2 μM.
The mean difference between the maximum stimulatory response
and the ZEP (parameter C, Figure 1) was 3.7-fold. This was calculated on
the basis of an average ZEP of 16.9 μM and an average stimulatory con-
centration of 4.6 μM. The 3.7-fold interval is within the value of 3- to 6-
fold reported in the published literature (Calabrese and Baldwin 1997).
The number of concentrations below the ZEP strongly influenced the
parameters assessed in this study. When there were more concentrations
below the ZEP, the zone of stimulation (parameter B) was wider, the dis-
tance from the maximum stimulatory concentration (Cmax) to the ZEP
(parameter C) was larger, and the ZEP itself was greater (Table 1). The
number of concentrations below the ZEP also had an impact on the
amplitude (parameter A) of the maximum stimulated response. The
amplitude increased approximately 12% (from 118.8% to 130.6%; Table
1) when going from 1 to 4 concentrations below the ZEP. The increase at
each category of “numbers of concentrations below the ZEP” was statisti-
cally significant (p < .05, two sample t-test) relative to the preceding cate-
gory (i.e., 1 vs. 2; 2 vs. 3; 3 vs. 4).
It is highly unlikely that a single toxicological mechanism can explain
the multitude of observed biphasic concentration-responses. Calabrese
(2001) has suggested that the stimulatory response at low concentrations
is generally the result of an initial disruption in homeostasis, and it
appears to represent a modest overcompensation response. The stimula-
tory response is usually slight because a compensatory process only mod-
estly overshoots the original physiological set-point. This slight overshoot,
or overcompensation phenomenon, ensures that the system efficiently
returns to homeostasis, thus avoiding an unnecessary and excessive waste
of resources. The data presented here are consistent with a slight over-
compensation, represented by a relatively small stimulatory response aver-
aging 27% above controls. A more complete analysis of the magnitude
would require inclusion of a temporal component to examine the con-
centration-responses over time, which is not possible in the NCI database.
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It is also difficult to speculate on a specific molecular mechanism that
may account for the various hormetic concentration-response curves
observed here because the compounds represent diverse chemical struc-
tures and biological activity. They include spindle poisons (such as vinca
alkaloids, taxanes, benzimidazoles), ribonucleotide reductase inhibitors
(such as triapine), antipsychotics (such as Haldoperidol), antibiotics
(such as congocidine), mustard agents, histological stains (such as toluy-
lene blue and acridine yellow), halocarbonyls, and nitroaromatics, to
name only a few (Holbeck and Simon, 2007; NCI, 2007). While many of
the compounds are effective at inhibiting the proliferation of a particular
mutated yeast strain, their precise molecular targets and mechanisms of
action are not known in many cases (Holbeck and Simon 2007). Thus, it
is difficult to speculate on the molecular mechanisms that stimulate cell
proliferation at low concentrations. While a single mechanism is unlikely
to apply to all of the compounds in this drug screen, a common general
mechanism that has emerged in a study of over 120 different anticancer
drug biphasic concentration-responses is that of a 2-receptor subtype
model (Calabrese 2005). In this scenario, one receptor would have high
and the other low affinity for the agonist. A biphasic concentration-
response would result from the high affinity receptor becoming activated
at the lower concentrations and the low affinity/high capacity receptor
becoming dominant at the higher concentrations (Szabadi 1977).
Studies related to drug development should be designed in a way that
accurately estimates the NOEL (no observed effect level, or the highest
dose that is not statistically different from the control value) so that
hormesis can be assessed (Calabrese et al 2006b). Assessment of horme-
sis can be important clinically; for example, if an anticancer drug were to
stimulate tumor cells at low doses, hormesis would be an adverse effect to
be avoided. In this database of approximately 28,500 concentration-
responses only about 22,200 (78%) showed the requisite high dose inhi-
bition (hmax) required by our a priori criteria, and 17,660 of these did not
show stimulation (Smin) of at least 10% greater than the control value.
Thus, more concentrations in the sub-threshold zone would be needed
for about 62% of the concentration-responses in order to accurately
assess the possibility of hormetic effects. 
It has been proposed that an initial screening should accurately esti-
mate the toxic threshold (such as the ZEP), and then follow-up testing
should be done to evaluate the presence of hormesis (Calabrese et al.
2006b). This may be prudent given that 52.5% (n = 1,150) of the 2,189
anticancer agents evaluated in the NCI Yeast Anticancer Drug Screen dis-
play hormetic concentration-responses in at least one of the 13 yeast
strains, and 24 putative anticancer agents showed hormetic concentration-
responses in all of the 13 strains (Table 2). The amplitude of stimulation,
width of the hormetic zone, and distance from the maximum stimulatory
10
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response to the ZEP were generally greater when hormetic responses for
a given agent were observed in more yeast strains (Table 2). There is also
a tendency for the quantified parameters of the hormetic region (i.e., A,
B, or C in Figure 1) to increase as the slope of the distance from the IC50
to the ZEP becomes greatest (i.e., the IC50-ZEP value is smallest).
Caution is required when attempting to identify chemical structures
of “hormetic” compounds because the structures of all compounds have
not been unequivocally verified. For example, Holbeck and Simon
(2007) report a case in which one of the compounds identified as a spe-
cific inhibitor of the rad50 and rad52 strains had a different structure
than was indicated by the supplier.
The observation of hormetic responses in over 50% of the chemicals
evaluated and all 13 yeast strains suggests that the biphasic dose-response
is generalizable for many different chemical agents and varied genotypes.
Thus, the responses following exposure to alkylating agents, antimetabo-
lites, DNA cutters, DNA binders, and many other classes of compounds
(Holbeck and Simon 2007) exhibit similar quantitative features. The
results reported here are consistent with quantitative features of hormet-
ic responses seen in published literature for various biological models,
(i.e., plant, microbe, invertebrate, vertebrate, in vitro, in vivo), endpoints
(e.g., growth, fecundity, tissue repair, cognition, lifespan) and stressors
(toxicants, endogenous agonists, synthetic agonists, radiation, physical
stressor) [Calabrese and Blain 2005]. The consistency of the findings for
a large database of systematically conducted tests with excellent quality
TABLE 2. The mean value of the quantified features of the hormetic concentration-responses. The
“No. of Strains Hormetic” refers to the number of yeast strains that a particular “Chemical Agent”
passed the a priori entry and evaluative criteria. For example, there were 24 chemical agents that
passed the entry criteria in all 13 yeast strains yielding a total of 312 concentration-responses.
Mean Value of Respective Parameter
No. of Strains Chemical Concentration- A B C ZEP IC50 
Hormetic Agents Responses (% Control) (µM) (µM) (µM) (µM)
1 419 419 120.31 5.78 10.18 16.18 47.83
2 183 366 121.21 7.18 11.18 17.36 45.91
3 91 273 119.92 5.92 10.42 16.27 47.26
4 75 300 119.74 7.25 10.89 16.02 45.98
5 64 320 121.13 7.65 10.30 15.62 54.09
6 55 330 122.52 8.90 12.60 16.93 48.45
7 46 322 124.14 10.04 13.22 17.94 45.70
8 49 392 124.45 7.86 10.46 14.54 46.94
9 38 342 126.85 11.40 14.31 18.95 39.49
10 29 290 129.94 10.32 14.09 17.28 45.36
11 42 462 134.54 11.36 13.42 16.89 46.35
12 35 420 141.42 12.83 13.90 17.62 44.05
13 24 312 142.48 12.07 14.54 18.19 42.91
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control (Holbeck 2004; Holbeck and Simon 2007) and the toxicological
literature more broadly (Calabrese and Blain 2005) argues that there is
coherence in the quantitative attributes of hormesis. This suggests a
broadly based biological plasticity that may represent a general biological
principle in responding to stress.
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